FDA clears infusion pump with Dose IQ software from Baxter
Baxter (NYSE:BAX) announced today that the FDA issued 510(k) clearance to its Novum IQ infusion pump with Dose IQ safety software.
Stay updated with breaking news from Illinois Based Baxter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Baxter (NYSE:BAX) announced today that the FDA issued 510(k) clearance to its Novum IQ infusion pump with Dose IQ safety software.
Baxter (NYSE:BAX) announced that it expanded its partnership with The Links to improve awareness and resources related to kidney health.
Baxter (NYSE:BAX) today issued long-term financial guidance that projects growth over the next three years.
Baxter announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes.
Baxter (NYSE:BAX) announced today that it received FDA 510(k) clearance for its ST Set in continuous renal replacement therapy (CRRT).